rolipram has been researched along with Dementia in 2 studies
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, M | 1 |
| Nishibayashi, S | 1 |
| Iwata, E | 1 |
| Kondo, Y | 1 |
| Nakanishi, T | 1 |
| Vargas, MG | 1 |
| Ogawa, N | 1 |
| Hirai, S | 1 |
2 other studies available for rolipram and Dementia
| Article | Year |
|---|---|
Alterations of cAMP response element-binding activity in the aged rat brain in response to administration of rolipram, a cAMP-specific phosphodiesterase inhibitor.
Topics: Afferent Pathways; Aging; Animals; Choline O-Acetyltransferase; Cyclic AMP; Cyclic AMP Response Elem | 1996 |
[Clinical application of enzyme inhibitors for dementia].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Brain; | 1991 |